Close

Magic™ Bioactive Peptide Discovery Service

Background Service Platform Features Case Study FAQs Resources

Introduction of Peptide Ligands

Peptide ligand-protein interactions play a crucial role in signal transduction and cellular functions. To identify high-affinity and high-specificity peptide ligands among thousands of competitors, a rapid and robust screening method is required. Fortunately, phage-displayed peptide libraries have proven to be an effective tool for exploring peptide ligands.

The development of peptide ligands has broad application prospects, including:


Creative Biolabs provides a high-throughput and rapid method for sequencing peptide ligands isolated from the screening, which capitalizes on next-generation DNA sequencing and bioinformatics analysis of the selected phage clones. In combination with our high-quality premade peptide libraries, we can provide up to 300 unique bioactive peptides for a variety of targets in a short time.

Magic™ Bioactive Peptide Discovery Service

Creative Biolabs offers the high-throughput Magic™ platform for bioactive peptide discovery. This powerful platform rapidly characterizes all clones in the screened library to identify one or more peptide families that specifically bind to the target protein. The main steps are as follows:

01Constructing the Peptide Library

Create a phage display library containing a diverse range of peptide sequences. These sequences are randomly displayed on the phage surface, offering numerous potential binding peptides.

02Screening the Library

Incubate the library with the target protein (such as receptors, enzymes, antibodies, etc.) to allow specific binding. Wash away unbound phages, retaining only those that bind to the target protein.

03Enriching Binding Peptides

Recover phages that bind to the target protein and amplify them to increase the number of specific binding peptides. Repeat this screening and amplification process (known as panning) for multiple rounds (typically three to five) to improve specificity and enrichment.

04Sequencing & Analysis

Use next-generation DNA sequencing (NGS) to sequence the selected phages and obtain the peptide sequences they display. Perform bioinformatics analysis to identify peptides with high affinity and specificity for the target protein.

05Validation & Optimization

Validate the binding ability of the selected candidate peptides in vitro. Further improve peptide affinity and stability through mutagenesis and optimization strategies, producing highly active peptide ligands.

Fig.1 The overview of phage display technology.Fig.1 Phage display for peptides and antibodies discovery.1

Comprehensive Tech Platform

Featured Properties of our Magic™ Bioactive Peptides Discovery Service

Case Study

Fig. 2 A peptide sequencing data supports a successful project to select cyclic heptapeptide libraries. (Creative Biolabs Original)Fig. 2 The peptide sequences of the selected cyclic heptapeptide libraries were determined through sequencing.

Our laboratory developed highly specific cyclic heptapeptides that can bind to target proteins and reconstitute them. Through sequencing, we identified the peptide sequences of the selected cyclic heptapeptide library and discovered several potential candidate peptides.

FAQ

  1. Q: What types of phage libraries are available for peptide screening?

    A: There are several types of phage libraries available, including M13 phage libraries, T7 phage libraries, cDNA libraries, and constrained peptide libraries. Each type is designed to display a diverse range of peptides or proteins that can be screened against your target of interest.

  2. Q: How do you ensure the specificity of the peptides identified through phage display?

    A: Specificity is ensured through multiple rounds of panning (binding, washing, and elution) with increasing stringency in the washing steps. Additionally, negative selection steps can be included to remove peptides that bind to non-target molecules.

  3. Q: Can the peptides identified through phage display be synthesized for further use?

    A: Yes, once high-affinity peptides are identified through phage display, they can be synthesized chemically for further use in research, therapeutic development, or diagnostic applications. These peptides can also be modified to enhance their stability, affinity, or specificity.

  4. Q: Can you modify the identified peptides to improve their properties?

    A: Yes, once high-affinity peptides are identified, they can be chemically synthesized and modified to enhance their stability, affinity, or specificity. Modifications may include cyclization, incorporation of non-natural amino acids, or conjugation to other molecules.


If you are interested or have a current requirement for high-affinity peptide ligands, please do not hesitate to contact us. Creative Biolabs is here to support your projects with cutting-edge technology and unparalleled expertise.

Resources

Use the resources in our library to help you understand your options and make critical decisions for your study.

Videos Podcasts Infographic Flyer Articles
Reference
  1. Zhao, Hui, et al. "Phage display-derived peptides and antibodies for bacterial infectious diseases therapy and diagnosis." Molecules 28.6 (2023): 2621. Distributed under Open Access license CC BY 4.0. The image was modified by revising the title.

All listed services and products are For Research Use Only. Do Not use in any diagnostic or therapeutic applications.

Online Inquiry
CONTACT US
USA:
Europe:
Germany:
Call us at:
USA:
UK:
Germany:
Fax:
Email:
Our customer service representatives are available 24 hours a day, 7 days a week. Contact Us
© 2024 Creative Biolabs. | Contact Us